Mucosal leishmaniasis in a Sudanese patient.
Mucosal leishmaniasis (ML) is an oral disease caused by the parasite Leishmania donovani. The disease has been proven to be pandemic in many areas of the world. It affects young men living in leishmaniasis-endemic areas. ML might be accompanied or proceeded by visceral leishmaniasis (VL), although in most of the cases seen in Sudan, ML occurs as a primary lesion. ML can mimic oral cancer or fungal infections, with ulceration as the most common finding in ML lesions. In this report, the patient came from an area known to be endemic for VL. Although the lesions were not ulcerative, the patient history was indicative for ML. Early detection and proper diagnosis were of great help in the cure and prognosis of the disease.
Abbas
Kamal
K
Department of Oral and Maxillofacial Surgery, Department of Orthodontics, Genetics Section, University of Khartoum, Faculty of Dentistry, Khartoum, Sudan. kamalabbas@hotmail.com
Musatafa
Mayson A
MA
Abass
Shaza
S
Kheir
Musa M
MM
Mukhtar
Maowia
M
Elamin
Elwaleed M
EM
Elhassan
Ahmed M
AM
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D009067:Mouthwashes / Q000008:administration & dosage / Q000627:therapeutic use; D013397:Sudan
D000981:Antiprotozoal Agents; D009067:Mouthwashes; C068538:liposomal amphotericin B; D000666:Amphotericin B; C010882:chlorhexidine gluconate; D002710:Chlorhexidine